The Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held today i.e. 9th February 2026 has approved the following: 01. Grant of Options 02. Modification in Vesting Schedule of ESOPs 03. Allotment of Equity Shares.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]